Inventor · disambiguated record
Qiufen Xue
Also filed as: XUE QIUFEN · XUE QIUFEN M · XUE QIUFEN MAY
37 granted patents·25 pending applications·421 citations·filing 2000–2025
97Inventor score
Top patents by PatentIndex Score
62 records- 0198US11766436B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2021·Granted Sep 26, 2023·11 cites·19 claims
- 0298US11090304B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2019·Granted Aug 17, 2021·33 cites·3 claims
- 0398US7354924B2Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Apr 8, 2008·106 cites·6 claims
- 0497US7662823B2Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 16, 2010·17 cites·8 claims
- 0597US7501420B2Composition and antiviral of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Mar 10, 2009·21 cites·10 claims
- 0696US12083121B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2022·Granted Sep 10, 2024·7 cites·5 claims
- 0796US11285156B2Substituted piperazines as KRAS G12C inhibitorsAMGEN INC·Filed 2019·Granted Mar 29, 2022·16 cites·4 claims
- 0896US9611261B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Apr 4, 2017·25 cites·40 claims
- 0995US9085576B2Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Jul 21, 2015·31 cites·60 claims
- 1093US12440491B2KRAS G12C inhibitors and methods of using the sameAMGEN INC·Filed 2023·Granted Oct 14, 2025·1 cites·4 claims
- 1191US6900206B2Indole, azaindole and related heterocyclic sulfonylureido piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 31, 2005·28 cites·15 claims
- 1288US6573262B2Composition and antiviral activity of substituted indoleoxoacetic piperazine derivativesBRISTOL MYERS SQIBB COMPANY·Filed 2001·Granted Jun 3, 2003·44 cites·33 claims
- 1388US2025381187A1Kras g12c inhibitors and methods of using the sameAMGEN INC·Filed 2025·Application pending·0 cites
- 1487US7714019B2Indole, azaindole and related heterocyclic pyrrolidine derivativesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted May 11, 2010·3 cites·2 claims
- 1586US7872009B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jan 18, 2011·11 cites·8 claims
- 1684US9296698B2Amino heteroaryl compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2010·Granted Mar 29, 2016·5 cites·14 claims
- 1784US6750246B1C-4 carbonate taxanesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jun 15, 2004·29 cites·13 claims
- 1881US7531552B2Indole, azaindole and related heterocyclic pyrrolidine derivativesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 12, 2009·3 cites·2 claims
- 1980US9556135B2Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Granted Jan 31, 2017·2 cites·38 claims
- 2077US7745484B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Jun 29, 2010·2 cites·15 claims
- 2176US8883782B2Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of useCHENG YUAN·Filed 2011·Granted Nov 11, 2014·4 cites·18 claims
- 2275US12459932B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Nov 4, 2025·1 cites·34 claims
- 2375US12441736B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·1 cites·31 claims
- 2475US2014135342A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2574US2015087652A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 2673US9296759B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2012·Granted Mar 29, 2016·2 cites·11 claims
- 2773US9296734B2Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2014·Granted Mar 29, 2016·2 cites·39 claims
- 2873US2010093752A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Application pending·0 cites
- 2973US2013289046A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 3072US7973047B2Beta-Secretase modulators and methods of useAMGEN INC·Filed 2010·Granted Jul 5, 2011·2 cites·21 claims
- 3172US6916942B2Process for the preparation of C-4 carbonate taxanesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 12, 2005·4 cites·30 claims
- 3271US6362217B2Taxane anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Mar 26, 2002·7 cites·18 claims
- 3370US9777019B2Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of useAMGEN INC·Filed 2016·Granted Oct 3, 2017·1 cites·13 claims
- 3470US7838676B2Beta-secretase modulators and methods of useAMGEN INC·Filed 2006·Granted Nov 23, 2010·1 cites·11 claims
- 3570US2016207918A1Substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3670US2012238583A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsWANG TAO·Filed 2012·Application pending·0 cites
- 3770US2016152615A1Prodrugs of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3869US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 3969US2016075703A1Substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4068US2015329543A1Prodrugs of substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4166US2015259342A1Substituted azaindoleoxoacetic piperazine derivativesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4266US2011245268A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 4365US2004110785A1Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivativesFiled 2003·Application pending·0 cites
- 4465US2011118279A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2011·Application pending·0 cites
- 4564US2012095017A1Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives with protease inhibitorsWANG TAO·Filed 2011·Application pending·0 cites
- 4660US8163909B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted Apr 24, 2012·0 cites·17 claims
- 4758US2014107109A1Amino-dihydrothiazine and amino-dioxido dihydrothiazine compounds as beta-secretase antagonists and methods of useAMGEN INC·Filed 2013·Application pending·0 cites
- 4857US2006287531A1Indole, azaindole and related heterocyclic pyrrolidine derivativesKADOW JOHN F·Filed 2006·Application pending·0 cites
- 4956US8173810B2Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of useZHONG WENGE·Filed 2008·Granted May 8, 2012·0 cites·17 claims
- 5055US2006094717A1Indole, azaindole and related heterocyclic ureido and thioureido piperazine derivativesREGUEIRO-REN ALICIA·Filed 2005·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →